Bridgebio pharma inc.

NA

BBIO


421 Kipling Street
Palo Alto , CA 94301

Executive/
Director

Price

  • Last Close
  • $ 28.09
    $ -0.13 -0.46 %
    Jan 3, 2025
  • 52-Week High/Low
  • $43.89 - $23
  • YTD
  • 2.4%

  • Trading Volume
  • 32,492
  • Market Cap Full
  • $ 4.9B
  • Shares Outstanding
  • 174M
    Oct 26, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -13.9% -39.2% 117.6% -23.4% 2.4%
Q2 - - - - 4% -0.5% -10.5% 3.7% -15.8% -
Q3 - - - -27.1% 8% -23.1% 9.5% 53.3% -2.5% -
Q4 - - - 71% 89.5% -64.4% -23.3% 58.9% -7% -
J F M A M J J A S O N D
2025 2.4% - - - - - - - - - - -
2024 -15.1% -0.4% -9.5% -19.9% 13.1% -9.8% -0% -2.5% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%100%-77%-54%430%-32%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - -1.18 -1.35 -0.92
Q2 - - - - - -0.66 -0.07 -0.98
Q3 - - - 0.51 - -1.06 -0.93 -1.08
Q4 - - - - - -1 -0.91 -
A 0 0 0 0.5 -3.8 -3.9 -3.3 -2.98

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 123.8 149 147.6 151.4
Jun - 121.4 149.3 147.7 160.5
Sep 116.8 122.4 149.8 148.2 162.5
Dec 123.6 122.6 147.2 149.5 174

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 2.2 1.1 0.2 0.7 -
Total Asset Turnover 0.1 0.1 - 0.1 -
Leverage
Debt Ratio 3.1 1.9 0.7 0.2 0.1
Debt – Equity Ratio -1.4 -2 4.5 0.2 0.2
Interest Coverage 16.5 41.2 19 53.2 3.5
Equity multiplier - -0.1 0.4 0.1 0.1